| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.0099 | 1 |